Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Shares Issued (2017 - 2025)

iBio (IBIO) has disclosed Shares Issued for 14 consecutive years, with $218970.0 as the latest value for Q4 2025.

  • On a quarterly basis, Shares Issued fell 98.79% to $218970.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $219113.0, a 98.6% decrease, with the full-year FY2025 number at $113.0, down 100.0% from a year prior.
  • Shares Issued was $218970.0 for Q4 2025 at iBio, up from $30.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $18.1 million in Q4 2024 to a low of -$6.9 million in Q1 2024.
  • A 4-year average of $1.4 million and a median of $77000.0 in 2021 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: soared 17960.0% in 2024, then crashed 125.33% in 2025.
  • iBio's Shares Issued stood at $77000.0 in 2021, then rose by 29.87% to $100000.0 in 2023, then skyrocketed by 17960.0% to $18.1 million in 2024, then tumbled by 98.79% to $218970.0 in 2025.
  • Per Business Quant, the three most recent readings for IBIO's Shares Issued are $218970.0 (Q4 2025), $30.0 (Q3 2025), and -$1.1 million (Q2 2025).